查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1417709

生物製程驗證市場報告：2030 年趨勢、預測與競爭分析

Bioprocess Validation Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

生物製程驗證的趨勢和預測

2024年至2030年，全球生物製程驗證市場將以9.5%的複合年成長率成長。該市場的主要促進因素是確保安全和品質標準的日益嚴格的法規、生物製藥行業需求的增加以及對外包生物製程驗證的興趣日益濃厚。全球生物製程驗證市場的未來充滿希望，製藥、生物技術、合約研究和受託製造廠商市場充滿機會。

生物製程驗證市場洞察

Lucintel 預測，由於生物製藥製造商增加了測試服務外包，可提取性/浸出性測試服務在預測期內仍將是最大的細分市場。

由於生物製藥產量的增加，製藥公司仍將是市場上最大的部分。

由於生物製程驗證服務外包趨勢的上升以及該地區政府的積極舉措，預計亞太地區在預測期內將出現最高成長。

常問問題

Q1.市場成長預測如何？

A1. 從 2024 年到 2030 年，全球生物製程驗證市場預計將以 9.5% 的複合年成長率成長。

Q2.影響市場成長的主要促進因素有哪些？

A2. 該市場的主要驅動力是確保安全和品質標準的日益嚴格的法規、生物製藥行業不斷成長的需求以及對外包生物製程驗證的興趣日益成長。

Q3.市場的主要細分市場有哪些？

A3. 生物製程驗證市場的未來對於製藥公司、生技公司以及合約開發和受託製造廠商市場來說是充滿希望的。

Q4.市場上主要企業有哪些？

A4.主要的生物製程驗證公司如下。

  • Merck
  • SGS
  • Eurofins Scientific
  • Sartorius
  • Pall

Q5.未來最大的細分市場是什麼？

A5.Lucintel 預計，由於生物製藥製造商增加了測試服務外包，可提取性/浸出性測試服務在預測期內仍將是最大的細分市場。

Q6. 未來五年預計哪個地區將成為最大的市場？

A6. 由於生物製程驗證服務外包的趨勢不斷增加以及該地區政府的積極舉措，預計亞太地區在預測期內將出現最高的成長。

Q7. 可以客製化報告嗎？

A7. 是的，Lucintel 提供 10% 的客製化服務，無需額外費用。

目錄

第1章執行摘要

第2章全球生物製程驗證市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球生物製程驗證市場趨勢（2018-2023）與預測（2024-2030）
  • 按測試類型分類的全球生物程序驗證市場
    • 萃取物/可浸出物測試服務
    • 微生物檢測服務
    • 完整性測試服務
    • 其他
  • 按工藝組件分類的全球生物程序驗證市場
    • 濾芯
    • 媒體容器和媒體袋
    • 冷凍和解凍加工袋
    • 混合系統
    • 反應器
    • 輸送系統
    • 其他
  • 按最終用途分類的全球生物製程驗證市場
    • 製藥公司
    • 生技公司
    • 合約開發和製造組織
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 按地區分類的全球生物程序驗證市場
  • 北美生物製程驗證市場
  • 歐洲生物程序驗證市場
  • 亞太生物製程驗證市場
  • 其他地區的生物製程驗證市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按測試類型分類的全球生物程序驗證市場成長機會
    • 按工藝組件分類的全球生物程序驗證市場成長機會
    • 按最終用途分類的全球生物程序驗證市場成長機會
    • 按地區分類的全球生物程序驗證市場成長機會
  • 全球生物製程驗證市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球生物程序驗證市場的能力
    • 全球生物程序驗證市場的合併、收購和合資企業
    • 認證和許可

第7章主要企業概況

  • Merck
  • SGS
  • Eurofins Scientific
  • Sartorius
  • Pall
簡介目錄

Bioprocess Validation Trends and Forecast

The future of the global bioprocess validation market looks promising with opportunities in the pharmaceutical company, biotechnology company, and contract development & manufacturing organization markets. The global bioprocess validation market grow with a CAGR of 9.5% from 2024 to 2030. The major drivers for this market are increasing strict rules to ensure safety and quality standards, growing demand from biopharmaceutical industry, and rising interest in outsourcing the validation of bioprocesses.

A more than 150-page report is developed to help in your business decisions.

Bioprocess Validation by Segment

The study includes a forecast for the global bioprocess validation by test type, process component, end use, and region.

Bioprocess Validation Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

  • Extractables/Leachables Testing Services
  • Microbiological Testing Services
  • Integrity Testing Services
  • Others

Bioprocess Validation Market by Process Component [Shipment Analysis by Value from 2018 to 2030]:

  • Filter Elements
  • Media Containers and Bags
  • Freezing and Thawing Process Bags
  • Mixing Systems
  • Bioreactors
  • Transfer Systems
  • Others

Bioprocess Validation Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Development & Manufacturing Organizations
  • Others

Bioprocess Validation Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Bioprocess Validation Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bioprocess validation companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bioprocess validation companies profiled in this report include-

  • Merck
  • SGS
  • Eurofins Scientific
  • Sartorius
  • Pall

Bioprocess Validation Market Insights

Lucintel forecasts that extractable/leachable testing service will remain the largest segment over the forecast period due to rising outsourcing of testing services by biopharmaceutical manufacturers.

Within this market, pharmaceutical company will remain the largest segment due to rising production levels of biopharmaceuticals.

APAC is expected to witness highest growth over the forecast period due to growing trend toward outsourcing bioprocess validation services and favourable government intiatives in the region.

Features of the Global Bioprocess Validation Market

Market Size Estimates: Bioprocess validation market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Bioprocess validation market size by test type, process component, end use, and region in terms of value ($B).

Regional Analysis: Bioprocess validation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different test types, process components, end uses, and regions for the bioprocess validation market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bioprocess validation market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for bioprocess validation market?

Answer: The global bioprocess validation market is expected to grow with a CAGR of 9.5% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the bioprocess validation market?

Answer: The major drivers for this market are increasing strict rules to ensure safety and quality standards, growing demand from biopharmaceutical industry, and rising interest in outsourcing the validation of bioprocesses.

Q3. What are the major segments for bioprocess validation market?

Answer: The future of the bioprocess validation market looks promising with opportunities in the pharmaceutical company, biotechnology company, and contract development & manufacturing organization markets.

Q4. Who are the key bioprocess validation market companies?

Answer: Some of the key bioprocess validation companies are as follows.

  • Merck
  • SGS
  • Eurofins Scientific
  • Sartorius
  • Pall

Q5. Which bioprocess validation market segment will be the largest in future?

Answer: Lucintel forecasts that extractable/leachable testing service will remain the largest segment over the forecast period due to rising outsourcing of testing services by biopharmaceutical manufacturers.

Q6. In bioprocess validation market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to growing trend toward outsourcing bioprocess validation services and favourable government intiatives in the region.

Q.7 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the bioprocess validation market by test type (extractables/leachables testing services, microbiological testing services, integrity testing services, and others), process component (filter elements, media containers and bags, freezing and thawing process bags, mixing systems, bioreactors, transfer systems, and others), end use (pharmaceutical companies, biotechnology companies, contract development & manufacturing organizations, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Bioprocess Validation Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Bioprocess Validation Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Bioprocess Validation Market by Test Type
    • 3.3.1: Extractables/Leachables Testing Services
    • 3.3.2: Microbiological Testing Services
    • 3.3.3: Integrity Testing Services
    • 3.3.4: Others
  • 3.4: Global Bioprocess Validation Market by Process Component
    • 3.4.1: Filter Elements
    • 3.4.2: Media Containers and Bags
    • 3.4.3: Freezing and Thawing Process Bags
    • 3.4.4: Mixing Systems
    • 3.4.5: Bioreactors
    • 3.4.6: Transfer Systems
    • 3.4.7: Others
  • 3.5: Global Bioprocess Validation Market by End Use
    • 3.5.1: Pharmaceutical Companies
    • 3.5.2: Biotechnology Companies
    • 3.5.3: Contract Development & Manufacturing Organizations
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Bioprocess Validation Market by Region
  • 4.2: North American Bioprocess Validation Market
    • 4.2.2: North American Bioprocess Validation Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Contract Development & Manufacturing Organizations, and Others
  • 4.3: European Bioprocess Validation Market
    • 4.3.1: European Bioprocess Validation Market by Test Type: Extractables/Leachables Testing Services, Microbiological Testing Services, Integrity Testing Services, and Others
    • 4.3.2: European Bioprocess Validation Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Contract Development & Manufacturing Organizations, and Others
  • 4.4: APAC Bioprocess Validation Market
    • 4.4.1: APAC Bioprocess Validation Market by Test Type: Extractables/Leachables Testing Services, Microbiological Testing Services, Integrity Testing Services, and Others
    • 4.4.2: APAC Bioprocess Validation Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Contract Development & Manufacturing Organizations, and Others
  • 4.5: ROW Bioprocess Validation Market
    • 4.5.1: ROW Bioprocess Validation Market by Test Type: Extractables/Leachables Testing Services, Microbiological Testing Services, Integrity Testing Services, and Others
    • 4.5.2: ROW Bioprocess Validation Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Contract Development & Manufacturing Organizations, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Bioprocess Validation Market by Test Type
    • 6.1.2: Growth Opportunities for the Global Bioprocess Validation Market by Process Component
    • 6.1.3: Growth Opportunities for the Global Bioprocess Validation Market by End Use
    • 6.1.4: Growth Opportunities for the Global Bioprocess Validation Market by Region
  • 6.2: Emerging Trends in the Global Bioprocess Validation Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Bioprocess Validation Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bioprocess Validation Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Merck
  • 7.2: SGS
  • 7.3: Eurofins Scientific
  • 7.4: Sartorius
  • 7.5: Pall